Bolt Biotherapeutics, Inc. — Investor Relations & Filings
Bolt Biotherapeutics is a clinical-stage biotechnology company developing immuno-oncology therapies to treat cancer. The company's approach leverages the innate immune system, particularly myeloid cells, to create a therapeutic anti-tumor response. Its proprietary Boltbody™ Immune-stimulating Antibody Conjugate (ISAC) platform combines tumor-targeting antibodies with immune-stimulating agents. This technology is designed to repolarize tumor-supportive immune cells, such as macrophages, into tumor-destructive ones, while also activating the adaptive immune system. The company's pipeline includes multiple candidates generated from the ISAC platform and other novel approaches. A key candidate, BDC-3042, is a first-in-class Dectin-2 agonist antibody being evaluated in clinical trials.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - Bolt Biotherapeutics, Inc. (0001641281) (Filer) | 2026-05-12 | English | |
| SCHEDULE 13D/A Filing | 2026-02-17 | English | |
| SCHEDULE 13G/A Filing | 2026-02-13 | English | |
| 4 Filing | 2026-02-04 | English | |
| 4 Filing | 2026-02-04 | English | |
| 4 Filing | 2026-02-04 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
6 filings
| |||||
| 45339379 | 10-Q - Bolt Biotherapeutics, Inc. (0001641281) (Filer) | 2026-05-12 | English | ||
| 31069040 | SCHEDULE 13D/A Filing | 2026-02-17 | English | ||
| 31069064 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 31069148 | 4 Filing | 2026-02-04 | English | ||
| 31069044 | 4 Filing | 2026-02-04 | English | ||
| 31069037 | 4 Filing | 2026-02-04 | English | ||
|
2025
9 filings
| |||||
| 12870704 | 4 | 2025-12-16 | English | ||
| 12870716 | 4 | 2025-12-16 | English | ||
| 12870706 | 4 | 2025-12-16 | English | ||
| 12870705 | 4 | 2025-12-16 | English | ||
| 12870712 | 4 | 2025-12-16 | English | ||
| 12870708 | 4 | 2025-12-16 | English | ||
| 12870709 | 4 | 2025-12-16 | English | ||
| 12870714 | 4 | 2025-12-16 | English | ||
| 12870710 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ajanta Pharma Ltd.
Specialty pharmaceutical firm focused on complex generics a…
|
AJANTPHARM | IN | Manufacturing |
|
Akari Therapeutics Plc
Develops next-gen antibody-drug conjugates using proprietar…
|
AKTX | US | Manufacturing |
|
Akebia Therapeutics, Inc.
A biopharmaceutical company that develops and commercialize…
|
AKBA | US | Manufacturing |
|
Akeso, Inc.
Global commercial-stage biopharma developing innovative ant…
|
9926 | KY | Manufacturing |
|
Aktis Oncology, Inc.
A clinical-stage biotech developing targeted alpha radiopha…
|
AKTS | US | Manufacturing |
|
Akums Drugs and Pharmaceuticals Limited
CDMO providing end-to-end pharmaceutical manufacturing and …
|
AKUMS | IN | Manufacturing |
|
Albert David Ltd.
Produces pharmaceutical formulations, infusions, and specia…
|
ALBERTDAVD | IN | Manufacturing |
|
Aldeyra Therapeutics, Inc.
Develops medications for immune-mediated ocular and systemi…
|
ALDX | US | Manufacturing |
|
Aleafia Health Inc.
Vertically integrated cannabis company with cultivation, pr…
|
AH | CA | Manufacturing |
|
Alector, Inc.
Clinical-stage biotech using immuno-neurology to treat neur…
|
ALEC | US | Manufacturing |
Bolt Biotherapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35210/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35210 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35210 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35210 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35210}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Bolt Biotherapeutics, Inc. (id: 35210)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.